相关实验视频

Updated: Jul 24, 2025

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

作为EGFR抑制剂的植物化学衍生物的基于碎片的计算设计

Gayathri Shama Bhat¹, Fayaz Shaik Mohammad¹

¹Department of Biotechnology, Manipal Institute of Technology, Manipal, 576104, Karnataka, India.

Chemistry & biodiversity

|July 3, 2023

概括

针对表皮生长因子受体 (EGFR) 的新型植物化学衍生物显示出对阿尔茨海默病 (AD) 治疗有希望. 这些化合物可以克服耐药性,为AD提供新的治疗途径.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
计算化学计算化学

背景情况:

表皮生长因子受体 (EGFR) 是阿尔茨海默病 (AD) 的潜在治疗点.
目前针对阿尔茨海默氏症的EGFR抑制剂仅限于特定的化学类 (奎纳,奎诺林,氨基胺).
潜在的药物耐药性突变,类似于癌症,对阿尔茨海默病治疗构成了未来的挑战.

研究的目的:

通过向EGFR来确定潜在的阿尔茨海默病 (AD) 治疗的新型化学支架.
探索传统脑疾病疗法中的植物化学物质,作为新药发现的基础.
设计和计算评估用于EGFR抑制的新型植物化学衍生物.

主要方法:

基于碎片的计算药物设计被用来创建新型化合物.
进行了广泛的in silico分析,包括ADMET和SoM (结构-活动关系) 预测.
进行了分子模拟研究,以评估与EGFR的结合稳定性.

主要成果:

设计了新的植物化学衍生物 (PCD),PCD1,PCD8和PCD10显示出预测的血脑屏障透性.
ADMET和SoM分析表明,这些PCD具有有利的类似药物的特性.
PCD1和PCD8显示与EGFR的稳定相互作用,表明对抗药物耐药突变的潜在有效性.

结论:

设计的植物化学衍生物 (PCD) 是阿尔茨海默病 (AD) 的EGFR新型抑制剂.
这些化合物具有有利的药理动力学特性,并稳定地与EGFR结合.
即使存在耐药性突变,PCD1和PCD8也具有治疗AD的潜力,这需要进一步的实验验证.

关键词:

阿尔茨海默病的疾病阿尔茨海默病的疾病.基于碎片的药物发现.自然产品是自然产品的产品.神经病原体的神经病原体的神经病原体接收器接收器的接收器是什么

更多相关视频

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...